BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the first implantations of the Lumax DX System, a ...

WASHINGTON -- Researchers made a strong case that earlier was better when it comes to catheter ablation of ventricular tachycardias (VTs) in people with implantable cardiac defibrillators (ICDs).

Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer first device shocks but perhaps at a cost, the APPRAISE ATP randomized trial ...

Please provide your email address to receive an email when new articles are posted on . Patients with HF who received an implantable cardioverter defibrillator that detected severe sleep apnea may be ...

Combined data from five implantable cardioverter-defibrillator (ICD) trials suggest that it is the underlying arrhythmic disorder, rather than the ICD therapy itself, that affects mortality in these ...

Ventricular tachycardia (VT) ablation should be considered after the first implantable cardioverter defibrillator (ICD) shock in patients with ischemic or nonischemic cardiomyopathy, the PARTITA trial ...